Literature DB >> 12744688

Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic.

Begoña Cerdá1, José J Cerón, Francisco A Tomás-Barberán, Juan Carlos Espín.   

Abstract

The water-soluble ellagitanin punicalagin has been reported to be toxic to cattle. Taking into account that this antioxidant polyphenol is very abundant in pomegranate juice (> or =2 g/L), the present study evaluated the possible toxic effect of punicalagin in Sprague-Dawley rats upon repeated oral administration of a 6% punicalagin-containing diet for 37 days. Punicalagin and related metabolites were identified by HPLC-DAD-MS-MS in plasma, liver, and kidney. Five punicalagin-related metabolites were detected in liver and kidney, that is, two ellagic acid derivatives, gallagic acid, 3,8-dihydroxy-6H-dibenzo[b,d]pyran-6-one glucuronide, and 3,8,10-trihydroxy-6H-dibenzo[b,d]pyran-6-one. Feedstuff intake, food utility index, and growth rate were lower in treated rats during the first 15 days without significant adverse effects, which could be due to the lower nutritional value of the punicalagin-enriched diet together with a decrease in its palatability (lower food intake). No significant differences were found in treated rats in any blood parameter analyzed (including the antioxidant enzymes gluthatione peroxidase and superoxide dismutase) with the exception of urea and triglycerides, which remained at low values throughout the experiment. Although the reason for the decrease is unclear, it could be due to the lower nutritional value of the punicalagin-enriched diet with respect to the standard rat food. Histopathological analysis of liver and kidney corroborated the absence of toxicity. In principle, the results reported here, together with the large safety margin considered, indicate the lack of toxic effect of punicalagin in rats during the 37 day period investigated. However, taking into account the high punicalagin content of pomegranate-derived foodstuffs, safety evaluation should be also carried out in humans with a lower dose and during a longer period of intake.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12744688     DOI: 10.1021/jf020842c

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  60 in total

Review 1.  Use of Polyphenolic Compounds in Dermatologic Oncology.

Authors:  Adilson Costa; Michael Yi Bonner; Jack L Arbiser
Journal:  Am J Clin Dermatol       Date:  2016-08       Impact factor: 7.403

2.  Cardioprotective and hepatoprotective effects of ellagitannins from European oak bark (Quercus petraea L.) extract in rats.

Authors:  Sunil K Panchal; Lindsay Brown
Journal:  Eur J Nutr       Date:  2011-11-22       Impact factor: 5.614

3.  Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin.

Authors:  Xuan Zou; Chunhong Yan; Yujie Shi; Ke Cao; Jie Xu; Xun Wang; Cong Chen; Cheng Luo; Yuan Li; Jing Gao; Wentao Pang; Jialong Zhao; Fei Zhao; Hao Li; Adi Zheng; Wenyan Sun; Jiangang Long; Ignatius Man-Yau Szeto; Youyou Zhao; Zhizhong Dong; Peifang Zhang; Junkuan Wang; Wuyuan Lu; Yong Zhang; Jiankang Liu; Zhihui Feng
Journal:  Antioxid Redox Signal       Date:  2014-02-18       Impact factor: 8.401

4.  Nutritional and antinutritional composition of the five species of aquatic edible insects consumed in Manipur, India.

Authors:  T Shantibala; R K Lokeshwari; H Debaraj
Journal:  J Insect Sci       Date:  2014-01-26       Impact factor: 1.857

5.  Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions.

Authors:  Ephraim P Lansky; Wenguo Jiang; Huanbiao Mo; Lou Bravo; Paul Froom; Weiping Yu; Neil M Harris; Ishak Neeman; Moray J Campbell
Journal:  Invest New Drugs       Date:  2005-01       Impact factor: 3.850

6.  Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor.

Authors:  Mee Young Hong; Navindra P Seeram; David Heber
Journal:  J Nutr Biochem       Date:  2008-05-13       Impact factor: 6.048

7.  Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis.

Authors:  Satomi Koyama; Laura J Cobb; Hemal H Mehta; Navindra P Seeram; David Heber; Allan J Pantuck; Pinchas Cohen
Journal:  Growth Horm IGF Res       Date:  2009-10-22       Impact factor: 2.372

8.  Punicalagin inhibits inflammation in LPS-induced RAW264.7 macrophages via the suppression of TLR4-mediated MAPKs and NF-κB activation.

Authors:  Xiaolong Xu; Peng Yin; Changrong Wan; Xinlu Chong; Mingjiang Liu; Peng Cheng; Jiajia Chen; Fenghua Liu; Jianqin Xu
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

9.  The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans.

Authors:  Begoña Cerdá; Juan Carlos Espín; Soledad Parra; Pedro Martínez; Francisco A Tomás-Barberán
Journal:  Eur J Nutr       Date:  2004-01-06       Impact factor: 5.614

10.  Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of pro-inflammatory cytokines by inhibiting the activation of MAP Kinases and NF-kappaB in human KU812 cells.

Authors:  Zafar Rasheed; Nahid Akhtar; Arivarasu N Anbazhagan; Sangeetha Ramamurthy; Meenakshi Shukla; Tariq M Haqqi
Journal:  J Inflamm (Lond)       Date:  2009-01-08       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.